✦ LIBER ✦

Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer

✍ Scribed by Carlos L Arteaga

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Trastuzumab as a

✍ Vogel, C. L. 📂 Article 📅 2002 🏛 American Society of Clinical Oncology 🌐 English ⚖ 88 KB

First-line, single-agent Herceptin® (tra

✍ C. Vogel; M.A. Cobleigh; D. Tripathy; J.C. Gutheil; L.N. Harris; L. Fehrenbacher 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 151 KB

An exploratory study of sunitinib in com

✍ Fatima Cardoso; Jean-Luc Canon; Dino Amadori; Daniela Aldrighetti; Jean-Pascal M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 383 KB

Lapatinib or trastuzumab in combination

✍ Sally Doss; Janet Robertson; Jane Adam 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 42 KB

Phase 2, Multicenter, Single-Arm Study o

✍ Wilks, Sharon; Puhalla, Shannon; O'Shaughnessy, Joyce; Schwartzberg, Lee; Berrak 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 169 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB